DCG-IV Catalog No.:M20043-C InChi: InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4

InChi: InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4

Lumiracoxib (oral administration

with a pKi of 9

ClH/c1-4-14-12-24(2)10-9-21-15-7-5-6-8-17(15)23-22(21

DCG-IV Catalog No.:M20043-C InChi: InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4DCG IV is a potent agonist of group II mGluRs with EC50s of 0. 35 and 0. 09 M for mGlu2R and mGlu3R, reapectively. DCG IV is also a competitive antagonist at group I (IC50: mGlu1R 5R=389 630 M) and III receptors (IC50: mGlu4R 6R 7R 8R= 22. 5 39. 6 40. 1 32 M). DCG IV has anticonvulsive and neuroprotective effects. Product information CAS Number: 147782 19 2 Molecular Weight: 203. 15 Formula: C7H9NO6 Chemical Name: (1R,2R) 3 [(S)